Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 1772 for cancer

Edit search filters
  1. Melodi Matrix™ In Breast Reconstruction

    Rochester, MN

  2. Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

    Rochester, MN

  3. A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Participants With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments

    Rochester, MN

  4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  5. A Study To See If Memantine Protects The Brain During Radiation Therapy Treatment For A Brain Tumor

    Rochester, MN

  6. A Study To Clinically Test The Use Of A Prostate Cancer Knowledge Questionnaire

    Rochester, MN

  7. Paclitaxel, Ifosfamide And Cisplatin (TIP) Versus Bleomycin, Etoposide And Cisplatin (BEP) For Patients With Previously Untreated Intermediate- And Poor-risk Germ Cell Tumors

    Rochester, MN

  8. Phase 1-2 Study Of Low Dose ASTX727 (ASTX727 LD) In Lower Risk Myelodysplastic Syndromes

    Jacksonville, FL, Rochester, MN

  9. Polyphenon E in Treating Patients with High-Risk of Colorectal Cancer

    Rochester, MN

  10. A Study Screening Mammograms for Women in Their 40s: Mammography Choice

    Rochester, MN

.

Mayo Clinic Footer